Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or ß-thalassaemia: an open-label, multicentre, phase 2 study.
Lancet
; 400(10351): 493-501, 2022 08 13.
Article
en En
| MEDLINE
| ID: mdl-35964609
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Piperazinas
/
Quinolinas
/
Talasemia beta
/
Talasemia alfa
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2022
Tipo del documento:
Article